Kinetic analysis of myocardial uptake and negative inotropic effect of amiodarone in rat heart

European Journal of Pharmaceutical Sciences

Volumn 28, Issue 3, 2006, Pages 243-248

  Sermsappasuk, Pakawadee ^a   Baek, Myoungki ^a   Weiss, Michael ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Amiodarone; Negative inotropy; Pharmacokinetic pharmacodynamic model; Rat heart; Uptake

Indexed keywords

AMIODARONE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG INFUSION; DRUG UPTAKE; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE; INOTROPISM; ISOLATED HEART; MALE; NONHUMAN; PARTITION COEFFICIENT; PRIORITY JOURNAL; RAT; SIGMOID;

AMIODARONE; ANIMALS; ANTI-ARRHYTHMIA AGENTS; HEART; KINETICS; MALE; MODELS, BIOLOGICAL; MYOCARDIAL CONTRACTION; MYOCARDIUM; RATS; RATS, WISTAR; VENTRICULAR FUNCTION, LEFT; VENTRICULAR PRESSURE;

EID: 33646762863     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2006.02.007     Document Type: Article

References (22)

1. Beder S.D., Cohen M.H., and BenShachar G. Time course of myocardial amiodarone uptake in the piglet heart using a chronic animal model. Pediatr. Cardiol. 19 (1998) 204-211
2. Bicer S., Patchell J.S., Hamlin D.M., and Hamlin R.L. Acute effects of escalating doses of amiodarone in isolated guinea pig hearts. J. Vet. Pharmacol. Ther. 25 (2002) 221-226
3. Connolly S.J. Evidence-based analysis of amiodarone efficacy and safety. Circulation 100 (1999) 2025-2034
4. D'Argenio D.Z., and Schumitzky A. ADAPT II User's guide: Pharmacokinetic/Pharmacodynamic Systems Analysis Software (1997), Biomedical Simulations Resource, Los Angeles
5. Desai A.D., Chun S., and Sung R.J. The role of intravenous amiodarone in the management of cardiac arrhythmias. Ann. Intern. Med. 127 (1997) 294-303
6. Dobson G.P., and Cieslar J.H. Intracellular, interstitial and plasma spaces in the rat myocardium in vivo. J. Mol. Cell. Cardiol. 29 (1997) 3357-3363
7. Gray D.F., Mihailidou A.S., Hansen P.S., Buhagiar K.A., Bewick N.L., Rasmussen H.H., and Whalley D.W. Amiodarone inhibits the Na+-K+ pump in rabbit cardiac myocytes after acute and chronic treatment. J. Pharmacol. Exp. Ther. 284 (1998) 75-82
8. Jun A.S., and Brocks D.R. High-performance liquid chromatographic assay of amiodarone in rat plasma. J. Pharm. Pharm. Sci. 4 (2001) 263-268
9. Kang W., and Weiss M. Influence of P-glycoprotein modulators on cardiac uptake, metabolism and effects of idarubicin. Pharm. Res. 18 (2001) 1535-1541
10. Latini R., Tognoni G., and Kates R.E. Clinical pharmacokinetics of amiodarone. Clin. Pharmacokinet. 9 (1984) 136-156
11. Lubic S.P., Nguyen K.P., Dave B., and Giacomini J.C. Antiarrhythmic agent amiodarone possesses calcium channel blocker properties. J. Cardiovasc. Pharmacol. 24 (1994) 707-714
12. Mager D.E., and Jusko W.J. Pharmacodynamic modeling of time-dependent transduction systems. Clin. Pharmacol. Ther. 70 (2001) 210-216
13. Najjar T.A. Disposition of amiodarone in rats after single and multiple intraperitoneal doses. Eur. J. Drug Metab. Pharmacokinet. 26 (2001) 65-69
14. Nishimura M., Follmer C.H., and Singer D.H. Amiodarone blocks calcium current in single guinea pig ventricular myocytes. J. Pharmacol. Exp. Ther. 251 (1989) 650-659
15. Peters P.G., and Hayball P.J. A comparative analysis of the loss of amiodarone from small and large volume PVC and non-PVC infusion systems. Anaesth. Intensive Care 18 (1990) 241-245
16. Riva E., Gerna M., Neyroz P., Urso R., Bartosek I., and Guaitani A. Pharmacokinetics of amiodarone in rats. J. Cardiovasc. Pharmacol. 4 (1982) 270-275
17. Rhodes D.G., Newton R., Butler R., and Herbette L. Equilibrium and kinetic studies of the interactions of salmeterol with membrane bilayers. Mol. Pharmacol. 42 (1992) 596-602
18. Rodgers T., Leahy D., and Rowland M.J. Physiologically based pharmacokinetic modeling 1: predicting the tissue distribution of moderate-to-strong bases. J. Pharm. Sci. 94 (2005) 1259-1276
19. Shayeganpour A., Jun A.S., and Brocks D.R. Pharmacokinetics of amiodarone in hyperlipidemic and simulated high fat-meal rat models. Biopharm. Drug Dispos. 26 (2005) 249-257
20. Sugiyama A., Satoh Y., and Hashimoto K. Acute electropharmacological effects of intravenously administered amiodarone assessed in the in vivo canine model. Jpn. J. Pharmacol. 87 (2001) 74-82
21. Watanabe Y., and Kimura J. Inhibitory effect of amiodarone on Na(+)/Ca(2+) exchange current in guinea-pig cardiac myocytes. Br. J. Pharmacol. 131 (2000) 80-84
22. Weiss M. The anomalous pharmacokinetics of amiodarone explained by nonexponential tissue trapping. J. Pharmacokinet. Biopharm. 27 (1999) 383-396